CAS 78289-26-6

N-(2,6-dimethylphenyl)-1-(2-hydroxyethyl)piperidine-2-carboxamide

Description:

N-(2,6-dimethylphenyl)-1-(2-hydroxyethyl)piperidine-2-carboxamide, with the CAS number 78289-26-6, is a chemical compound that belongs to the class of piperidine derivatives. This substance features a piperidine ring, which is a six-membered nitrogen-containing heterocycle, and is substituted with a 2-hydroxyethyl group and a 2,6-dimethylphenyl moiety. The presence of the hydroxyl group suggests potential for hydrogen bonding, which may influence its solubility and reactivity. The dimethylphenyl group contributes to the compound's lipophilicity, potentially affecting its pharmacokinetic properties. This compound may exhibit biological activity, making it of interest in medicinal chemistry, particularly in the development of pharmaceuticals. Its structural characteristics suggest it could interact with various biological targets, although specific biological activities would need to be investigated through empirical studies. As with many organic compounds, safety and handling precautions should be observed, as the toxicity and environmental impact of this compound would depend on its specific properties and applications.

Formula: C₁₆H₂₄N₂O₂

InChI: InChI=1/C16H24N2O2/c1-12-6-5-7-13(2)15(12)17-16(20)14-8-3-4-9-18(14)10-11-19/h5-7,14,19H,3-4,8-11H2,1-2H3,(H,17,20)

SMILES: Cc1cccc(C)c1N=C(C1CCCCN1CCO)O

Synonyms:

• 2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-(2-hydroxyethyl)-

Droxicainide

CAS: 78289-26-6

Droxicainide

Purity: ≥98%

Molecular weight: 276.37g/mol

Ref: 54-BUP15155

Droxicainide

CAS: 78289-26-6

Droxicainide is a fatty acid ester that has been used in the treatment of cardiac arrhythmias. It works by binding to the calcium channel and preventing the passage of calcium ions into the cell, which prevents contractility. Droxicainide is not absorbed when taken orally and must be administered intravenously. This drug is typically given as a single dose, but may be given over a period of up to 24 hours. Droxicainide can also be given as an implantable long-term therapy for patients with chronic heart failure or atrial fibrillation. Droxicainide has been shown to be effective in reducing plasma concentrations of fatty alcohols and reconstituted pharmaceutical dosage forms containing fatty acids.

Formula: C₁₆H₂₄N₂O₂

Purity: Min. 95%

Molecular weight: 276.37 g/mol

Ref: 3D-DDA28926

Droxicainide

CAS: 78289-26-6

Droxicainide is an antiarrhythmic agent.

Formula: C₁₆H₂₄N₂O₂

Purity: 99.86%

Color and Shape: Solid

Molecular weight: 276.37

Ref: TM-T11099